The Blood Glucose Monitoring Systems Market report offers an in-depth analysis of various factors promoting and demoting the growth of the market during the mentioned forecast period. The information provided in the report is gathered from primary and secondary research methods.
As per the International Diabetes Foundation, the number of adults suffering from diabetes was around 425 million and is expected to reach 630 million by 2045. The prevalence of diabetes is primarily increasing owing to the rapid adoption of sedentary lifestyle and unhealthy food habits. This further shows that the demand for blood glucose monitoring systems will increase, thereby driving the globalblood glucose monitoring systems market. As per the report, the global market was valued at USD 10.09 Billion in the year 2018 and is projected to be worth USD 17.06 Billion by 2026. In addition to this, the global market is expected to exhibit a CAGR of 6.7% during the forecast period.
For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/blood-glucose-monitoring-market-100648
Highlights of the Report:
Key Players Operating in The Blood Glucose Monitoring Systems Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/rehabilitation-robots-market-101013
India and China to Account for 44% of the Global Diabetic Population
The prevalence of diabetes is increasing especially in countries such as China and India. Factors such as rapid growth in urbanization and lifestyle changes are responsible for this prevalence. Moreover, China and India hold 44% of the overall diabetic population worldwide.
High cost associated with diabetes monitoring systems is expected to hamper the growth of the market especially in developing economies. This is mainly because these countries lack a good and favorable reimbursement policy.
In countries such as the U.S., the average annual cost of continuous glucose monitoring systems is estimated to be between USD 2,500 and USD 2,800. On the other hand, the annual cost of test strips, lancets meters required for self-monitoring blood glucose (SMBG) devices is likely to fall between USD 5,000 to 5,200.
North America to Emerge Dominant Owing to Increasing Adoption of Technologically Advanced Systems
Among regions, North America is expected to maintain its dominance through the forecast years. This is ascribable to the rising awareness and expenditure about diabetes management. The rising adoption of technologically-advanced devices is another factor contributing to the growth. Some of the most recent blood sugar monitoring devices are more user-friendly, minimally-invasive, more convenient, and easy to handle.
Following North America, the market in Asia Pacific is expected to rise at a higher CAGR in the forecast years owing to the rising prevalence of diabetes. The International Diabetes Foundation found that around 7.1% of Indians suffered from diabetes in the year 2018. People in countries such as Japan, China, and Australia are continuously monitoring their blood glucose levels to maintain diabetes management.
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/blood-glucose-monitoring-market-100648
Detailed Table of Content:
. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.1 Prevalence of Diabetes, By Key Countries/ Key Regions, 2018
4.2 Pricing Analysis, By Key Regions/ Key Market Players
4.3 New Product Launches, By Key Market Players
4.4 Detailed Product Mapping, By Key Market Players
4.4 Recent Industry Developments Such As Mergers and Acquisitions
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast By Device
5.2.1 Continuous Glucose Monitoring Systems (CGM)
5.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
5.3. Market Analysis, Insights and Forecast By Type
5.3.1 Invasive
5.3.2 Non-Invasive
5.4 Market Analysis, Insights and Forecast By Modality
5.4.1 Wearable
5.4.2 Non- Wearable
5.5. Market Analysis, Insights and Forecast By Distribution Channel
5.5.1 Institutional Sales
5.5.2 Retail Sales
5.6. Market Analysis, Insights and Forecast By Region
5.6.1 North America
5.6.2 Europe
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5 Middle East and Africa
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast By Device
6.2.1 Continuous Glucose Monitoring Systems (CGM)
6.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
6.3. Market Analysis, Insights and Forecast By Type
6.3.1 Invasive
6.3.2 Non-Invasive
6.4. Market Analysis, Insights and Forecast By Modality
6.4.1 Wearable
6.4.2 Non- Wearable
6.5. Market Analysis, Insights and Forecast By Distribution Channel
6.5.1 Institutional Sales
6.5.2 Retail Sales
6.6. Market Analysis, Insights and Forecast By Country
6.6.1 U.S.
6.6.2 Canada
7.1. Key Findings / Summary
7.2. Market Analysis By Device
7.2.1 Continuous Glucose Monitoring Systems (CGM)
7.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
7.3. Market Analysis, Insights and Forecast By Type
7.3.1 Invasive
7.3.2 Non-Invasive
7.4. Market Analysis, Insights and Forecast By Modality
7.4.1 Wearable
7.4.2 Non- Wearable
7.5. Market Analysis, Insights and Forecast By Distribution Channel
7.5.1 Institutional Sales
7.5.2 Retail Sales
7.6. Market Analysis, Insights and Forecast By Country/ Sub-region
7.6.1 U.K
7.6.2 Spain
7.6.3 Germany
7.6.4 Italy
7.6.5 France
7.6.6 Scandinavia
7.6.7 Rest of Europe
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast By Device
8.2.1 Continuous Glucose Monitoring Systems (CGM)
8.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
8.3. Market Analysis, Insights and Forecast By Type
8.3.1 Invasive
8.3.2 Non-Invasive
8.4. Market Analysis, Insights and Forecast By Modality
8.4.1 Wearable
8.4.2 Non- Wearable
8.5. Market Analysis, Insights and Forecast By Distribution Channel
8.5.1 Institutional Sales
8.5.2 Retail Sales
8.6. Market Analysis, Insights and Forecast By Country/ Sub-region
8.6.1 China
8.6.2 India
8.6.3 Australia
8.6.4 Japan
8.6.5 Southeast Asia
8.6.6 Rest of Asia Pacific
Continued…
Report Focus:
Reasons to Purchase this Report:
KEY QUESTIONS ANSWERED:
More Trending Topics From Fortune Business Insights@
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Blood Glucose Monitoring Systems Market, conveys rigorous analysis of Industry and prospects to 2026